Ishita Drugs & Industries Q2 Results

  • BSE: 524400
  • NSE: -
  • ISIN: INE806D01016
  • Sector: Biotechnology & Drugs
BSE
89.022.96 (3.44%)
Volume27.19 K
Updated: Tue 26 Nov, 2024 | 15:28:27
NSE
This stock is not traded on NSE
Today: 84.30
91.50
52-Wk: 56.00
104.75

Q2 Results Highlights

  • Total Income
    ₹3.27 Cr.
    (8.15%)
  • Operating Profit
    ₹0.21 Cr.
    (44.86%)
  • Profit After Tax
    ₹0.19 Cr.
    (32.23%)
  • Operating Margin
    6.45%
    (52.26%)
Note: Comparison is on YoY basis

Quarterly - Ishita Drugs & Industries Q2 Results

*All figures in crores except per share values
Fiscal PeriodSep 24Jun 23QoQ CompSep 23YoY Comp
Total Revenue 3.273.09-%4.40-%
Selling/ General/ Admin Expenses Total 0.320.31-%0.35-%
Depreciation/ Amortization 0.030.03-%0.03-%
Other Operating Expenses Total 0.480.49-%0.54-%
Total Operating Expense 3.062.95-%4.21-%
Operating Income 0.210.13-%0.19-%
Net Income Before Taxes 0.260.18-%0.28-%
Net Income 0.190.14-%0.21-%
Diluted Normalized EPS 0.650.46-%0.70-%

Recommended For You

    More Recommendations

    Trending Stocks

      Subscribe to Our Newsletter

      Get daily newsletters around different themes from livemint.

      Subscribe
      HomeMarketsPremiumInstant LoanMint Shorts